TRAV19 and melanoma: Indeed, we reported before that MELOE-1 specific T cell repertoire was also a vast T cell repertoire in HLA-A2 healthy donors and melanoma patients, and that MELOE-1 specific T cells were strongly biased toward TRAV19 usage (2).